1. Pink Sheet
  2. >>Geography
  3. >>Europe

EU Parliament OKs Legislation To ‘Reduce Cost & Burden’ Of Patent Extensions

 
• By Ian Schofield

Legislation intended to remove the fragmentation in the supplementary protection certificate system has been OKd by the European Parliament, which will try to reach agreement with the EU member states following the June parliamentary elections.

Closing the gap
New EU legislation should produce a more joined up system for SPCs • Source: Shutterstock

New EU rules on extending the effective patent life of medicinal products drew nearer today after the European Parliament voted through two draft regulations that aim to make it easier to seek supplementary protection certificates (SPCs) with effect in all EU member states.

One of the regulations would allow companies to apply for an SPC in specified countries by filing a centralized application, rather than having to apply in each country separately. The other would introduce a “unitary SPC” to complement the EU’s unitary patent system, which came into operation in June 2023

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

US FDA Adcomm To Consider If Genentech’s Columvi Study Generalizable To US

 
• By Sue Sutter

Patients from Asia saw a differential treatment effect versus non-Asian regions in the Phase III multiregional study, with an adverse survival trend seen in the latter group, the FDA said about the lymphoma drug.

Califf In Conversation: ‘Decimated’ US FDA Teams Endanger Innovation

 
• By Barnaby Pickering

Pink Sheet sister publication In Vivo spoke to the former FDA commissioner about the recent layoffs and their impact on vaccine and other product development.

EU Shaping Biotech Act To Unleash SME Potential

 
• By Neena Brizmohun

European companies, in particular small and midsize enterprises, spin-offs and start-ups have a hard time expanding within the single market “because of a complex regulatory framework that is perceived as slow and burdensome,” according to the European Commission.